Saudi Arabia Pharmaceuticals Market Research Report: Forecast (2025-2030)

Pharmaceuticals Market in Saudi Arabia - By Molecule Type (Conventional Drugs [Small Molecules], Biologics & Biosimilars [Large Molecules]), By Product Type (Branded, Generics), By Drug Type (Prescrip... ... Drug Type (Prescription, Over-the-Counter), By Route of Administration (Oral [Tablets, Capsules, Suspensions, Others], Topical, Parenteral [Intravenous, Intramuscular], Inhalation), By Age Group (Adult, Children, Geriatric), By Disease (Cardiovascular Diseases, Cancer, Diabetes, Neurological Disorders, Respiratory Diseases, Autoimmune Diseases, Infectious Diseases, Gastrointestinal Disorders, Mental Health Disorders, Women’s Health Diseases, Dermatological Conditions, Haematological Disorders, Eye Conditions, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and By Region (North, East, West, Central) Read more

  • Healthcare
  • Sep 2025
  • 111
  • PDF, Excel, PPT

Market Insights & Analysis: Saudi Arabia Pharmaceuticals Market (2025-30):

The Saudi Arabia Pharmaceuticals Market size was valued at around USD 12.37 billion in 2025 and is projected to reach USD 18.12 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 7.93% during the forecast period, i.e., 2025-30. The Saudi Arabian Pharmaceuticals Industry is significantly growing due to several growth factors, including the growing efforts by the country’s government through heavy investments by introducing various policies such as the Made in Saudi Arabia Initiative, the Saudi Industrial Development Fund, and many more.

One of the most prominent growth factors is the growing burden of various health problems, such as diabetes, cardiovascular diseases, respiratory disorders, cancer, and infectious diseases, which are increasing the demand for recommended medications and treatments, thus increasing the market size & volume. Additionally, the government is supporting the market by investing heavily in infrastructure development to expand the pharmaceutical industry, including the construction of manufacturing plants, and rising foreign direct investments. These efforts are developing a favorable market environment for the market players to grow & flourish.

Moreover, the research and development have recently gained momentum in Saudi Arabia, backed by the rising investments through public and private partnerships, which have led to the adoption of advanced pharmaceutical products, including biologics and biosimilars in the country, as these are more effective and target specific, providing better treatments, thus uplifting the size & volume of Saudi Arabia Pharmaceuticals Industry.

Saudi Arabia Pharmaceuticals Market Scope:

 Category  Segments
By Product Type Branded, Generics
By Distribution Channel Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Molecule Type Conventional Drugs (Small Molecules) , Biologics & Biosimilars (Large Molecules)

Furthermore, the widespread presence of retail pharmacies in Saudi Arabia, with the broadest range of products, including drugs, vaccines, dietary supplements, cosmetics, etc., is attracting millions of people and increasing the market growth significantly. However, the country lacks production facilities, due to which it is highly dependent on the imports of pharmaceutical products, thus hindering further market growth.

Saudi Arabia Pharmaceuticals Market Driver:

Increasing Government Support to Expand Manufacturing Units – The market growth is driven by the growing efforts by the Saudi government to expand the local pharmaceutical manufacturing facilities in the country by drafting various policies, such as Vision 2030. For instance, in 2023, Saudi Arabia's sovereign wealth fund launched a contract development and manufacturing organization (CDMO) called Lifera, which aims to focus on the development of essential pharmaceutical products like vaccines, insulins, antibodies, etc. Recently, Saudi Arabia launched its first oncology pharmaceutical plant in Sudair city to increase local production and reduce import dependence. Consequently, more than 55 pharmaceutical factories are approved by the Saudi Food & Drug Authority (SFDA).

Moreover, the Saudi government aims to localize the production of about 70% of the essential medicines in the country by the end of 2030. These kinds of programs are heavily invested in by the government. For instance, in 2024, the national government allocated about USD5 billion in R&D, including drug discovery, thus driving the market growth.

  1. Market Segmentation
  2. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
  3. Executive Summary
  4. Saudi Arabia Pharmaceuticals Market Regulations, Policies & Standards
    1. Drug Registration & Approval Process (SFDA, etc.)
    2. Import/Export Regulations
    3. Patent Laws & IP Protection
    4. Pharmacovigilance & Compliance
    5. Recent Policy Changes (e.g. local manufacturing push)
  5. Saudi Arabia Healthcare Overview
    1. Economic Snapshot & Demographics
    2. Healthcare System Structure (Public vs. Private)
    3. Government Vision & Health Initiatives (e.g., Vision 2030)
  6. Saudi Arabia Pharmaceutical Local Manufacturing & Industrialization Push
    1. Saudi Arabia Pharma Manufacturing Landscape
    2. Incentives for Local Production
    3. Technology/Knowledge Transfer & R&D Capabilities
    4. Others
  7. Saudi Arabia Pharmaceuticals Market Trends & Developments
  8. Saudi Arabia Pharmaceuticals Market Dynamics
    1. Growth Drivers
    2. Challenges
  9. Saudi Arabia Pharmaceuticals Market Hotspots & Opportunities
  10. Saudi Arabia Pharmaceuticals Market Value Chain Analysis
  11. Saudi Arabia Pharmaceuticals Market Outlook, 2020- 2030F
    1. Market Size & Analysis
      1. Market Revenues (USD Million)
    2. Market Share & Analysis
      1. By Molecule Type
        1. Conventional Drugs (Small Molecules)- Market Size & Forecast 2020-2030, USD Million
        2. Biologics & Biosimilar (Large Molecules)- Market Size & Forecast
      2. By Product Type
        1. Branded- Market Size & Forecast 2020-2030, USD Million
        2. Generics- Market Size & Forecast 2020-2030, USD Million
      3. By Drug Type
        1. Prescription- Market Size & Forecast 2020-2030, USD Million
        2. Over the Counter- Market Size & Forecast 2020-2030, USD Million
      4. By Route of Administration
        1. Oral- Market Size & Forecast 2020-2030, USD Million
          1. Tablets- Market Size & Forecast 2020-2030, USD Million
          2. Capsules- Market Size & Forecast 2020-2030, USD Million
          3. Suspensions- Market Size & Forecast 2020-2030, USD Million
          4. Others- Market Size & Forecast 2020-2030, USD Million
        2. Topical- Market Size & Forecast 2020-2030, USD Million
        3. Parenteral- Market Size & Forecast 2020-2030, USD Million
          1. Intravenous- Market Size & Forecast 2020-2030, USD Million
          2. Intramuscular- Market Size & Forecast 2020-2030, USD Million
        4. Inhalation- Market Size & Forecast 2020-2030, USD Million
      5. By Age Group
        1. Adult- Market Size & Forecast 2020-2030, USD Million
        2. Children- Market Size & Forecast 2020-2030, USD Million
        3. Geriatric- Market Size & Forecast 2020-2030, USD Million
      6. By Disease
        1. Cardiovascular Diseases- Market Size & Forecast 2020-2030, USD Million
        2. Cancer- Market Size & Forecast 2020-2030, USD Million
        3. Diabetes- Market Size & Forecast 2020-2030, USD Million
        4. Neurological Disorders- Market Size & Forecast 2020-2030, USD Million
        5. Respiratory Diseases- Market Size & Forecast 2020-2030, USD Million
        6. Autoimmune Diseases- Market Size & Forecast 2020-2030, USD Million
        7. Infectious Diseases- Market Size & Forecast 2020-2030, USD Million
        8. Gastrointestinal Disorders- Market Size & Forecast 2020-2030, USD Million
        9. Mental Health Disorders- Market Size & Forecast 2020-2030, USD Million
        10. Women’s Health Diseases- Market Size & Forecast 2020-2030, USD Million
        11. Dermatological Conditions- Market Size & Forecast 2020-2030, USD Million
        12. Haematological Disorders- Market Size & Forecast 2020-2030, USD Million
        13. Eye Conditions- Market Size & Forecast 2020-2030, USD Million
        14. Others- Market Size & Forecast 2020-2030, USD Million
      7. By Distribution Channel
        1. Hospital Pharmacies- Market Size & Forecast 2020-2030, USD Million
        2. Retail Pharmacies- Market Size & Forecast 2020-2030, USD Million
        3. Online Pharmacies- Market Size & Forecast 2020-2030, USD Million
      8. By Region
        1. North
        2. East
        3. West
        4. Central
      9. By Competitors
        1. Competition Characteristics
        2. Market Share & Analysis
  12. Saudi Arabia Conventional Drugs (Small Molecules) Market Outlook, 2020- 2030F
    1. Market Size & Analysis
      1. Market Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product Type- Market Size & Forecast 2020-2030, USD Million
        1. Analgesics & Anti Inflammatory
        2. Antipyretic
        3. Antibiotics
        4. Antivirals
        5. Antidepressants
        6. Others
      2. By Drug Type- Market Size & Forecast 2020-2030, USD Million
      3. By Route of Administration- Market Size & Forecast 2020-2030, USD Million
      4. By Age Group- Market Size & Forecast 2020-2030, USD Million
      5. By Disease- Market Size & Forecast 2020-2030, USD Million
      6. By Distribution Channel- Market Size & Forecast 2020-2030, USD Million
      7. By End User- Market Size & Forecast 2020-2030, USD Million
  13. Saudi Arabia Biologics & Biosimilar (Large Molecules) Market Outlook, 2020- 2030F
    1. Market Size & Analysis
      1. Market Revenues (USD Million)
    2. Market Share & Analysis
      1. By Type - Market Size & Forecast 2020-2030, USD Million
        1. Monoclonal Antibodies- Market Size & Forecast 2020-2030, USD Million
        2.  Growth Factors- Market Size & Forecast 2020-2030, USD Million
        3.  Insulin- Market Size & Forecast 2020-2030, USD Million
        4.  Vaccines- Market Size & Forecast 2020-2030, USD Million
        5.  Therapeutic Enzymes- Market Size & Forecast 2020-2030, USD Million
        6.  Colony Stimulation Factors- Market Size & Forecast 2020-2030, USD Million
        7.  Interferons- Market Size & Forecast 2020-2030, USD Million
        8. Fusion Protein- Market Size & Forecast 2020-2030, USD Million
        9. Immunomodulators- Market Size & Forecast 2020-2030, USD Million
        10. Erythoprotein- Market Size & Forecast 2020-2030, USD Million
        11. Orthobiologics- Market Size & Forecast 2020-2030, USD Million
          1. Platelet-Rich Plasma (PRP)- Market Size & Forecast 2020-2030, USD Million
          2. Stem Cell Therapies- Market Size & Forecast 2020-2030, USD Million
          3. Hyaluronic Acid Injections- Market Size & Forecast 2020-2030, USD Million
          4. Growth Factors/Bone Morphogenetic Proteins (BMPs)- Market Size & Forecast 2020-2030, USD Million
    3. By Product Type- Market Size & Forecast 2020-2030, USD Million
    4. By Drug Type- Market Size & Forecast 2020-2030, USD Million
    5. By Route of Administration- Market Size & Forecast 2020-2030, USD Million
    6. By Age Group- Market Size & Forecast 2020-2030, USD Million
    7. By Disease- Market Size & Forecast 2020-2030, USD Million
    8. By Distribution Channel- Market Size & Forecast 2020-2030, USD Million
    9. By End User- Market Size & Forecast 2020-2030, USD Million
  14. Saudi Arabia Pharmaceuticals Market Key Strategic Imperatives for Growth & Success
  15. Competitive Outlook
    1. Company Profiles
      1. Pfizer
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      2. Sanofi
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      3. Novartis
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      4. SPIMACO
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      5. Tabuk Pharmaceuticals
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      6. Jamjoom Pharma
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      7. Riyadh Pharma
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      8. GlaxoSmithKline
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      9. Hikma Pharmaceuticals
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      10. AstraZeneca
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      11. Others
  16. Disclaimer


MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

Data Trangulation

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

Full Name*:

Company Name*:

Business Email*:

Country Name*:

Contact Number*:

Message:

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now
Inquire Before Buying
Customization Offered
  • Cross-segment Market Size & Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report
  • Go To Market Strategy
  • Region Specific Market Dynamics & Share
  • Import Export & Production Analysis
Request Customization
Related Reports